Paid Clinical Trials in Alberta Canada

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Alberta

Top of Directory » All Locations » Canada » Alberta




  • Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

    Conditions:   Breast Cancer;   Heart Failure
    Intervention:   Drug: perindopril (or placebo) OR bisoprolol (or placebo) OR both perindopril and bisoprolol OR placebo
    Sponsor:   University of Alberta
    Not yet recruiting - verified November 2009

  • A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)

    Conditions:   Renal Cell Carcinoma;   Cardiotoxicity;   Heart Failure;   Hypertension
    Intervention:  
    Sponsor:   University of Alberta
    Not yet recruiting - verified November 2009

  • Effect of Gastric Bypass on the Absorption of Metformin

    Conditions:   Obesity;   Gastric Bypass
    Intervention:  
    Sponsor:   University of Alberta
    Recruiting - verified November 2009

  • A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • RCT for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children

    Condition:   Asthma
    Interventions:   Drug: Azithromycin;   Drug: Placebo
    Sponsor:   Alberta Children's Hospital
    Not yet recruiting - verified November 2009

  • Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: linagliptin;   Drug: placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Augment™ Injectable Bone Graft Compared to Autologous Bone Graft in Foot and Ankle Fusions

    Condition:   Ankle/Hindfoot Fusion
    Interventions:   Device: Augment™ Injectable;   Procedure: Standard of care
    Sponsor:   BioMimetic Therapeutics
    Recruiting - verified November 2009

  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

    Condition:   H1N1/2009 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children

    Condition:   H1N1/2009 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009

  • A Study of Tocilizumab in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

    Condition:   Juvenile Idiopathic Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: tocilizumab;   Drug: placebo;   Drug: NSAIDs, corticosteroids, methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Dapagliflozin;   Drug: Placebo;   Drug: Hydrochlorothiazide
    Sponsors:   Bristol-Myers Squibb;   AstraZeneca
    Recruiting - verified November 2009

  • TMC435-TiDP16-C206: A Safety and Efficacy Study in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

    Condition:   Hepatitis C
    Interventions:   Drug: TMC435 placebo /Peg IFNa2A/Ribavirin;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435 placebo;   Drug: TMC435 /Peg IFNa2A/Ribavirin
    Sponsor:   Tibotec Pharmaceuticals, Ireland
    Recruiting - verified November 2009

  • A Study of RO5190591 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

    Condition:   Hepatitis C, Chronic
    Interventions:   Drug: RO5190591;   Drug: RO5190591;   Drug: RO5190591;   Drug: RO5190591;   Drug: Placebo;   Drug: Placebo;   Drug: Pegasys;   Drug: Copegus
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Clazosentan in Aneurysmal Subarachnoid Hemorrhage

    Condition:   Aneurysmal Subarachnoid Hemorrhage
    Interventions:   Drug: Clazosentan;   Drug: Clazosentan;   Drug: Placebo
    Sponsor:   Actelion
    Recruiting - verified November 2009

  • An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Intervention:   Drug: Dimebon
    Sponsors:   Pfizer;   Medivation, Inc.
    Recruiting - verified November 2009

  • 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

    Condition:   Schizophrenia
    Interventions:   Drug: paliperidone palmitate;   Drug: oral risperidone
    Sponsor:   Ortho-McNeil Janssen Scientific Affairs, LLC
    Recruiting - verified November 2009

  • Abatacept Versus Adalimumab Head-to-Head

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: Abatacept;   Drug: Adalimumab
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

    Condition:   Osteoporosis, Post-Menopausal
    Interventions:   Drug: Teriparatide;   Drug: Zoledronic Acid
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

    Condition:   Brain and Central Nervous System Tumors
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

    Conditions:   Chordoma;   Desmoid Tumor;   Sarcoma
    Interventions:   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: laboratory biomarker analysis
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Pharmacokinetic Study of Subcutaneous and Intravenous MabThera (Rituximab) in Patients With Follicular Lymphoma

    Condition:   Follicular Lymphoma
    Interventions:   Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan];   Drug: rituximab [MabThera/Rituxan]
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer

    Condition:   Small Cell Lung Carcinoma
    Interventions:   Drug: BMS-833923;   Drug: Carboplatin;   Drug: Etoposide
    Sponsors:   Bristol-Myers Squibb;   Exelixis
    Not yet recruiting - verified November 2009

  • Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older With the G551D Mutation

    Condition:   Cystic Fibrosis
    Interventions:   Drug: VX-770;   Drug: Placebo
    Sponsors:   Vertex Pharmaceuticals Incorporated;   Cystic Fibrosis Foundation
    Recruiting - verified November 2009

  • Effect of LY2062430 on the Progression of Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: LY2062430;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

    Condition:   Neuroblastoma
    Interventions:   Genetic: loss of heterozygosity analysis;   Other: cytology specimen collection procedure;   Procedure: biopsy
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Trans-Arterial Chemo-Embolization (TACE) Adjuvant Hepatocellular Carcinoma (HCC)

    Condition:   Hepatocellular Carcinoma
    Interventions:   Drug: Brivanib;   Drug: Brivanib Placebo
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified September 2009

  • Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study

    Condition:   Idiopathic Pulmonary Fibrosis
    Interventions:   Drug: ACT-064992 (macitentan);   Drug: Placebo
    Sponsor:   Actelion
    Recruiting - verified October 2009

  • Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

    Condition:   Sarcoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of Kidney Tumors in Young Patients

    Conditions:   Kidney Cancer;   Precancerous/Nonmalignant Condition
    Interventions:   Genetic: loss of heterozygosity analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

    Condition:   Sarcoma
    Interventions:   Other: biologic sample preservation procedure;   Other: medical chart review
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

    Conditions:   Leukemia;   Neoplasm of Uncertain Malignant Potential;   Unspecified Childhood Solid Tumor, Protocol Specific
    Intervention:   Other: cytology specimen collection procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma

    Condition:   Lymphoma
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Phase 2 Study of AMG 785 in Postmenopausal Women With Low Bone Mineral Density

    Conditions:   Low Bone Mineral Density;   Postmenopausal Osteoporosis
    Interventions:   Drug: AMG 785;   Drug: Active Comparator Alendronate;   Drug: Placebo;   Drug: AMG 785;   Drug: AMG 785;   Drug: AMG 785;   Drug: Placebo;   Drug: Active comparator teriparatide;   Drug: AMG 785
    Sponsor:   Amgen
    Recruiting - verified November 2009

  • A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Interventions:   Drug: BMS-708163;   Drug: Placebo
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified July 2009

  • NURTURE, the Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

    Condition:   Crohn's Disease
    Interventions:   Drug: certolizumab pegol;   Drug: certolizumab pegol;   Drug: certolizumab pegol
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009

  • Randomized Withdrawal Study of Desvenlafaxine Succinate Sustained Release in Outpatients With Major Depressive Disorder

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Desvenlafaxine succinate sustained release Dose A;   Drug: Placebo
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • An Extension to Study MA22460, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-TNF Therapy

    Condition:   Rheumatoid Arthritis
    Intervention:   Drug: tocilizumab
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

    Condition:   Prostate Cancer
    Interventions:   Drug: abiraterone acetate plus prednisone/prednisolone;   Drug: placebo plus prednisone/prednisolone
    Sponsor:   Cougar Biotechnology, Inc.
    Recruiting - verified November 2009

  • Effects of Pregabalin (Lyrica) on Sleep Maintenance in Subjects With Fibromyalgia

    Conditions:   Fibromyalgia;   Sleep Disorders
    Interventions:   Drug: Pregabalin;   Drug: Placebo
    Sponsor:   Pfizer
    Recruiting - verified October 2009

  • A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer

    Condition:   Endometrial Cancer
    Interventions:   Drug: Ixabepilone;   Drug: Doxorubicin;   Drug: Paclitaxel
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • TMC435-TiDP16-C205: A Phase II Study of TMC435 in Combination With Pegylated Interferon Alpha-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment

    Condition:   Hepatitis C
    Interventions:   Drug: TMC435 Ribavirin;   Drug: Ribavirin PegIFNalpha-2a;   Drug: TMC435 TMC435 Placebo;   Drug: TMC435 Ribavirin;   Drug: PegIFNalpha-2a;   Drug: Ribavirin PegIFNalpha-2a;   Drug: PegIFNalpha-2a;   Drug: PegIFNalpha-2a;   Drug: TMC435 TMC435 Placebo;   Drug: TMC435 Placebo Ribavirin
    Sponsor:   Tibotec Pharmaceuticals, Ireland
    Recruiting - verified November 2009

  • A Study of Patients With Relapsing Remitting Multiple Sclerosis

    Condition:   Relapsing-Remitting Multiple Sclerosis
    Interventions:   Drug: LY2127399;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease

    Condition:   Parkinson's Disease
    Interventions:   Drug: placebo;   Drug: IPX066;   Drug: IPX066;   Drug: IPX066
    Sponsor:   IMPAX Laboratories, Inc.
    Recruiting - verified November 2009

  • Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals With Herpes Simplex Virus Type 2?

    Conditions:   HIV Infection;   Herpesvirus 2, Human;   HIV Infections
    Interventions:   Drug: valacyclovir;   Drug: Placebo
    Sponsors:   University Health Network, Toronto;   Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz;   The Huesped Foundation
    Not yet recruiting - verified August 2009

  • Metabolic Abnormalities - OPT

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar I Disorder;   Metabolic Syndrome
    Interventions:   Drug: Aripiprazole;   Drug: Olanzapine;   Drug: Risperidone;   Drug: Quetiapine
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified July 2009

  • First Line Hepato Cellular Carcinoma (HCC)

    Condition:   Hepato Cellular Carcinoma (HCC)
    Interventions:   Drug: Brivanib;   Drug: Placebo;   Drug: Sorafenib;   Drug: Placebo
    Sponsor:   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).

    Condition:   Carcinoma, Hepatocellular
    Interventions:   Drug: Nexavar (Sorafenib, BAY43-9006);   Drug: Placebo
    Sponsor:   Bayer
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials